Gregory Levine > Ropes & Gray LLP > Washington DC, United States > Lawyer Profile
Ropes & Gray LLP Offices
2099 PENNSYLVANIA AVENUE, NW
WASHINGTON, DC 20006-6807
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Gregory Levine
Work Department
Israel
Position
Partner
Career
https://www.ropesgray.com/en/biographies/l/gregory-h-levine?AK=Greg%20Levine
Lawyer Rankings
United States > Healthcare > Life sciences
(Hall of Fame)Ropes & Gray LLP is particularly well versed in handling complex cross-border licensing agreements, and is also a name to note for transactions in the life sciences space. Additionally, the practice offers extensive expertise across a wide range of litigation, representing clients facing IP disputes and product liability class action, and is able to support clients seeking FDA approval for their products. The practice is headed jointly by transactional specialists Marc Rubenstein and Michael Beauvais, both of whom are based in Boston and maintain a broad transaction practice encompassing IPOs, licensing agreements and M&As in the sector, and Washington DC���s Gregory Levine, who focuses predominantly on assisting pharmaceutical, biotech and medical devices clients in navigating the FDA’s regulatory regime. Kellie Combs, also operating out of the capital, is noted for her knowledge of the Food, Drug, and Cosmetic Act and the Public Health Service Act, FDA promotional rules and the regulation of digital health systems.
Lawyer Rankings
Top Tier Firm Rankings
- Investment fund formation and management > Alternative/hedge funds
- Finance > Financial services regulation
- Dispute resolution > E-discovery
- Dispute resolution > Securities litigation: defense
- Dispute resolution > M&A litigation: defense
- Healthcare > Life sciences
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Healthcare > Service providers
Firm Rankings
- Finance > Capital markets: high-yield debt offerings
- Finance > Capital markets: equity offerings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Tax > Not-for-profit (Fortune 1000 private foundations, national trade associations, and charities)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Tax > US taxes: non-contentious
- Antitrust > Cartel
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (International Trade Commission)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Government > State attorneys general
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: high-yield debt offerings
- Finance > Fintech
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Antitrust > Civil litigation/class actions: defense
- M&A/corporate and commercial > Venture capital and emerging companies
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- International trade and national security > Customs, export controls and economic sanctions
- Finance > Structured finance: securitization
- M&A/corporate and commercial > Shareholder activism